AGN-195263

· Allergan

Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for AGN-195263, covering 2017-09-08 to 2019-02-19. Get the full timeline:

Most recent: Clinical Trial Update: Topical Ophthalmic AGN-195263 for the Treatment of Evaporative Dry Eye [Phase 3]